Cancer Genetics Inks Cervical Cancer Test Deal with Texas Pathology Services Provider | GenomeWeb

NEW YORK (GenomeWeb) – Cancer Genetics today said that it has signed a multi-year agreement with PathAdvantage Associated to offer its FHACT test, a FISH-based genomic test for detecting and managing cervical cancer, and to collaborate on research in support of the test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.